Kjell Rudolf Peter Edman
Director/Board Member at Edman Life Science AB
Net worth: 2 611 $ as of 2024-04-29
Profile
Kjell Rudolf Peter Edman is currently the Director at Edman Life Science AB.
He has previously worked as the Director-Global Development at AstraZeneca AB, Director at Biolipox AB, Managing Director at Svecia Engineering AB, Director at Xintela AB, and Director at Mind The Byte SL.
He also served as an Independent Director at Xbrane Biopharma AB from 2015 to 2024.
Additionally, he has held positions as Principal at Astra AB and Pharmacia AB, Chief Scientific Officer at Biovitrum AB, Chief Scientific Officer & Head-R&D at Orexo AB from 2012 to 2015, and Chief Scientific Officer & Vice President at Swedish Orphan Biovitrum AB from 2010 to 2011.
He has also worked as a Professor at the University of Uppsala and as an Associate Professor at The Medical Products Agency.
Dr. Edman holds a doctorate degree from the University of Uppsala.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0.01% | 2022-12-30 | 132,314 ( 0.01% ) | 2 611 $ | 2024-04-29 |
Kjell Rudolf Peter Edman active positions
| Companies | Position | Start |
|---|---|---|
| Edman Life Science AB | Director/Board Member | - |
Former positions of Kjell Rudolf Peter Edman
| Companies | Position | End |
|---|---|---|
| XBRANE BIOPHARMA AB | Director/Board Member | 2024-05-01 |
| OREXO AB | Chief Tech/Sci/R&D Officer | 2015-05-31 |
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2011-12-30 |
| XINTELA AB | Director/Board Member | - |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Training of Kjell Rudolf Peter Edman
| University of Uppsala | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| OREXO AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| XBRANE BIOPHARMA AB | Health Technology |
| XINTELA AB | Health Technology |
| Private companies | 9 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Pharmacia AB | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
Svecia Engineering AB
 Svecia Engineering AB Industrial MachineryProducer Manufacturing Svecia Engineering AB is a world-leading manufacturer of screen printing presses and ancillary equipment used extensively in the graphics, manufacturing and glass industries. Since its start-up in 1948, they have continuously introduced new ideas and products that have made screen printing a modern and reliable manufacturing technology. Today, more than 50 years later, their skills and dedication remain unchanged. Screen printing is still highly visual. Everyone can see how well you handle the mix of colors, materials and formats that characterizes the industry today. And everyone knows that the success of your business depends on the quality of your result. Committed to supplying innovative production solutions tailored to your total needs, their aim to increase your competitive edge and make you a first-choice supplier of screen printing services. | Producer Manufacturing |
Mind The Byte SL
 Mind The Byte SL Packaged SoftwareTechnology Services Mind The Byte SL develops software for drug discovery. | Technology Services |
The Medical Products Agency
 The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Health Technology |
| Edman Life Science AB |
- Stock Market
- Insiders
- Kjell Rudolf Peter Edman
